243 related articles for article (PubMed ID: 7600075)
1. Treatment of Paget's disease of bone with bisphosphonates.
Mazières B
Rev Rhum Engl Ed; 1995 Feb; 62(2):72-8. PubMed ID: 7600075
[No Abstract] [Full Text] [Related]
2. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
3. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy.
Pirih FQ; Zablotsky M; Cordell K; McCauley LK
J Mich Dent Assoc; 2009 May; 91(5):38-43. PubMed ID: 19537656
[TBL] [Abstract][Full Text] [Related]
4. Paget's disease of bone.
Haddad JG
Curr Ther Endocrinol Metab; 1994; 5():525-7. PubMed ID: 7704787
[No Abstract] [Full Text] [Related]
5. Treatment of Paget's bone disease with the bisphosphonate APD.
Mautalen CA
Henry Ford Hosp Med J; 1983; 31(4):244-8. PubMed ID: 6425243
[No Abstract] [Full Text] [Related]
6. Tiludronate for Paget's disease of bone.
Med Lett Drugs Ther; 1997 Jul; 39(1005):65-6. PubMed ID: 9255236
[No Abstract] [Full Text] [Related]
7. [Treatment of Paget's disease paraplegia with diphosphonates : preliminary results (author's transl)].
Alexandre C; Trillet M; Meunier P; Fischer C
Rev Neurol (Paris); 1979 Oct; 135(8-9):625-32. PubMed ID: 161056
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of Paget's disease of bone].
Ziegler R; Frank K
Dtsch Med Wochenschr; 1988 Jan; 113(3):102-5. PubMed ID: 3123193
[No Abstract] [Full Text] [Related]
9. 'Breaking the back' of Paget's bone disease.
Ryan WG
Arch Intern Med; 1989 Dec; 149(12):2639. PubMed ID: 2531996
[No Abstract] [Full Text] [Related]
10. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
Krane SM
Nat Clin Pract Rheumatol; 2006 Apr; 2(4):186-7. PubMed ID: 16932682
[No Abstract] [Full Text] [Related]
11. Paget's disease and bisphosphonates.
Rendina D; De Filippo G; Mossetti G
N Engl J Med; 2005 Dec; 353(24):2616-8; author reply 2616-8. PubMed ID: 16365936
[No Abstract] [Full Text] [Related]
12. Extensive personal experience: Paget's disease of bone.
Siris ES
J Clin Endocrinol Metab; 1995 Feb; 80(2):335-8. PubMed ID: 7852484
[No Abstract] [Full Text] [Related]
13. Pharmacological therapy of Paget's and other metabolic bone diseases.
Hosking D
Bone; 2006 Feb; 38(2 Suppl 2):S3-7. PubMed ID: 16406763
[TBL] [Abstract][Full Text] [Related]
14. Multiple fractures in a woman receiving 24 years of etidronate treatment for Paget's disease.
Labinson P; Taxel P
Conn Med; 2007 May; 71(5):269-73. PubMed ID: 17526382
[No Abstract] [Full Text] [Related]
15. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
[No Abstract] [Full Text] [Related]
16. Calcitonin and diphosphonate in the treatment of Paget's disease of bone.
Hosking DJ
Metab Bone Dis Relat Res; 1981; 3(4-5):317-26. PubMed ID: 6820113
[TBL] [Abstract][Full Text] [Related]
17. Paget's disease of the bone.
Hamdy RC
Clin Geriatr Med; 1994 Nov; 10(4):719-35. PubMed ID: 7850699
[TBL] [Abstract][Full Text] [Related]
18. Paget's disease of bone: presentation, extent and response to bisphosphonates.
Wang LM; Au-Yeong ML; McKenna MJ
Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
[TBL] [Abstract][Full Text] [Related]
19. Acquired resistance to bisphosphonates in Paget's disease of bone.
Papapoulos SE; Eekhoff EM; Zwinderman AH
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P88-91. PubMed ID: 17229015
[No Abstract] [Full Text] [Related]
20. Etidronate-an oral treatment for Paget's disease of bone.
Drug Ther Bull; 1982 Apr; 20(7):25-6. PubMed ID: 6804199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
